Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax

Journal of Medical Microbiology

Volumn 59, Issue 12, 2010, Pages 1415-1427

  Thomas, Richard ^a   Davies, Carwyn ^a   Nunez, Alejandro ^b   Hibbs, Stephen ^a   Flick Smith, Helen ^a   Eastaugh, Lin ^a   Smither, Sophie ^a   Gates, Amanda ^a   Oyston, Petra ^a   Atkins, Timothy ^a   Eley, Steve ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ANTHRAX VACCINE; BACILLUS ANTHRACIS RECOMBINANT PROTECTIVE ANTIGEN; BACTERIAL ANTIGEN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

A J MOUSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHRAX; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL ENDOSPORE; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFICACY; FEMALE; GASTRITIS; HISTOPATHOLOGY; INFECTION PREVENTION; INHALATION; KIDNEY; LIVER; LYMPHADENITIS; MEDIASTINUM LYMPH NODE; MESENTERIC LYMPHADENITIS; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PARTICLE SIZE; PEYER PATCH; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN; SURVIVAL; THYMUS; UPPER RESPIRATORY TRACT; VACCINATION;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; DISEASE MODELS, ANIMAL; FEMALE; MICE; PARTICLE SIZE;

EID: 78649419682     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.024117-0     Document Type: Article

References (59)

1. Beatty, M. E., Ashford, D. A., Griffin, P. M., Tauxe, R. V. & Sobel, J. (2003). Gastrointestinal anthrax: review of the literature. Arch Intern Med 163, 2527-2531.
2. Butler, T., Fu, Y. S., Furman, L., Almeida, C. & Almeida, A. (1982). Experimental Yersinia pestis infection in rodents after intragastric inoculation and ingestion of bacteria. Infect Immun 36, 1160-1167. (Pubitemid 12124836)
3. Cleret, A., Quesnel-Hellmann, A., Vallon-Eberhard, A., Vernier, B., Jung, S., Vidal, D., Mathieu, J. & Tournier, J. N. (2007). Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol 178, 7994-8001. (Pubitemid 46898070)
4. Day, W. C. & Berendt, R. F. (1972). Experimental tularaemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis. Infect Immun 5, 77-82.
5. Druett, H. A., Henderson, D. W., Packman, L. P. & Peacock, S. (1953). Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. J Hyg (Lond) 51, 359-371.
6. Druett, H. A., Robinson, J. M., Henderson, D. W., Packman, L. & Peacock, S. (1956a). The influence of aerosol particle size on infection of the guinea-pig with Pasteurella pestis. J Hyg (Lond) 54, 37-48.
7. Druett, H. A., Henderson, D. W. & Peacock, S. (1956b). Studies on respiratory infection. III. Experiments with Brucella suis. J Hyg (Lond) 54, 49-57.
8. Drysdale, M., Heninger, S., Hutt, J., Chen, Y., Lyons, C. R. & Koehler, T. M. (2005). Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J 24, 221-227. (Pubitemid 40188479)
9. Duc, L. H., Hong, H. A., Fairweather, N., Ricca, E. & Cutting, S. M. (2003a). Bacterial spores as vaccine vehicles. Infect Immun 71, 2810-2818.
10. Duc, L. H., Hong, H. A. & Cutting, S. M. (2003b). Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 21, 4215-4224.
11. Duncan, S. & Ho, J. (2008). Estimation of viable spores in Bacillus atrophaeus (BG) particles of 1 to 9 mm size range. Clean Soil Air Water 36, 584-592.
12. Duncan, E. J. S., Kournikakis, B., Ho, J. & Hill, I. (2009). Pulmonary deposition of aerosolized Bacillus atrophaeus in a swine model due to exposure from a simulated anthrax letter incident. Inhal Toxicol 21, 141-152.
13. + dendritic cells promote protective immunity to respiratory infection with Bordetella pertussis. J Immunol 183, 400-410.
14. Flick-Smith, H. C., Eyles, J. E., Hebdon, R., Waters, E. L., Beedham, R. J., Stagg, T. J., Miller, J., Alpar, H. O., Baillie, L. W. & Williamson, E. D. (2002). Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infect Immun 70, 2022-2028. (Pubitemid 34242204)
15. Flick-Smith, H. C., Waters, E. L., Walker, N. J., Miller, J., Stagg, A. J., Green, E. D. & Williamson, E. D. (2005). Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain. Microb Pathog 38, 33-40. (Pubitemid 40094516)
16. Frankel, A. E., Kuo, S. R., Dostal, D., Watson, L., Duesbery, N. S., Cheng, C. P., Cheng, H. J. & Leppla, S. H. (2009). Pathophysiology of anthrax. Front Biosci 14, 4516-4524.
17. Fritz, D. L., Jaax, N. K., Lawrence, W. B., Davis, K. J., Pitt, M. L., Ezzell, J. W. & Friedlander, A. M. (1995). Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest 73, 691-702.
18. Fujimura, Y., Takeda, M., Ikai, H., Haruma, K., Akisada, T., Harada, T., Sakai, T. & Ohuchi, M. (2004). The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling. Virchows Arch 444, 36-42. (Pubitemid 38200088)
19. Glomski, I. J., Corre, J.-P., Mock, M. & Goossens, P. L. (2007a). Nonencapsulated toxigenic Bacillus anthracis presents a specific growth and dissemination pattern in naïve and protective antigen-immune mice. Infect Immun 75, 4754-4761. (Pubitemid 47502144)
20. Glomski, I. J., Piris-Gimenez, A., Huerre, M., Mock, M. & Goossens, P. L. (2007b). Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3, e76.
21. Glomski, I. J., Dumetz, F., Jouvion, G., Huerre, M. R., Mock, M. & Goossens, P. L. (2008). Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect 10, 1398-1404.
22. Goossens, P. L. (2009). Animal models of human anthrax: the quest for the holy grail. Mol Aspects Med 30, 467-480.
23. Gueirard, P., Ave, P., Balazuc, A.-M., Thiberge, S., Huerre, M., Milon, G. & Guiso, N. (2003). Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract. Infect Immun 71, 4137-4143. (Pubitemid 36753743)
24. Guyton, A. C. (1947). Measurement of the respiratory volumes of laboratory animals. Am J Physiol 150, 70-77.
25. Heine, H. S., Bassett, J., Miller, L., Hartings, J. M., Ivins, B. E., Pitt, M. L., Fritz, D., Norris, S. L. & Byrne, W. R. (2007). Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Antimicrob Agents Chemother 51, 1373-1379. (Pubitemid 46586819)
26. Holty, J.-E. C., Bravat, D. M., Liu, H., Olshen, R. A., McDonald, K. M. & Owens, D. K. (2006a). Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med 144, 270-280.
27. Holty, J.-E. C., Kim, R. Y. & Bravata, D.M. (2006b). Anthrax: a systematic review of atypical presentations. Ann Emerg Med 48, 200-211.
28. Jahnsen, F. L., Gran, E., Haye, R. & Brandtzaeg, P. (2004). Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes. Am J Respir Cell Mol Biol 30, 31-37. (Pubitemid 38085256)
29. Jernigan, D. B., Raghunathan, P. L., Bell, B. P., Brechner, R., Bresnitz, E. A., Butler, J. C., Cetron, M., Cohen, M., Doyle, T. & other authors (2002). Investigation of bioterrorism-related anthrax, United States 2001: epidemiologic findings. Emerg Infect Dis 8, 1019-1028.
30. Kang, T. J., Basu, S., Zhang, L., Thomas, K. E., Vogel, S. N., Baillie, L. & Cross, A. S. (2008). Bacillus anthracis spores and lethal toxin induce IL-1β via functionally distinct signalling pathways. Eur J Immunol 38, 1574-1584.
31. Kang, T. J., Lee, G. S., Kim, S. K., Jin, S. H. & Chae, G. T. (2010). Comparison of two mice strains, A/J and C57BL/6, in caspase-1 activity and IL-1b secretion of macrophage to Mycobacterium leprae infection. Mediators Inflamm (in press).
32. Kwa, S.-F., Beverley, P. & Smith, A. L. (2006). Peyer's patches are required for the induction of rapid Th1 responses in the gut and mesenteric lymph nodes during an enteric infection. J Immunol 176, 7533-7541. (Pubitemid 43849057)
33. Lever, M. S., Stagg, A. J., Nelson, M., Pearce, P., Stevens, D. J., Scott, A. M., Simpson, A. J. H. & Fulop, M. J. (2008). Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus). Int J Exp Pathol 89, 171-179. (Pubitemid 351661564)
34. Loving, C. L., Kennett, M., Lee, G. M., Grippe, V. K. & Merkel, T. J. (2007). Murine aerosol challenge model of anthrax. Infect Immun 75, 2689-2698. (Pubitemid 46870149)
35. Loving, C. L., Khurana, T., Osorio, M., Lee, G. M., Kelly, V. K., Stibitz, S. & Merkel, T. J. (2009). Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun 77, 255-265.
36. Lyons, C. R., Lovchik, J., Hutt, J., Lipscomb, M. F., Wang, E., Heninger, S., Berliba, L. & Garrison, K. (2004). Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun 72, 4801-4809. (Pubitemid 38989340)
37. Macpherson, A. J. & Smith, K. (2006). Mesenteric lymph nodes at the center of immune anatomy. J Exp Med 203, 497-500.
38. Meyer, M. A. (2003). Neurologic complications of anthrax. Arch Neurol 60, 483-488.
39. Nicholson, W. L., Farjado-Cavazos, P., Rebeil, R., Slieman, T. A., Reisenman, P. J., Law, J. F. & Xue, Y. (2002). Bacterial endospores and their significance in stress resistance. Antonie van Leeuwenhoek 81, 27-32.
40. Owen, S. J., Batzloff, M., Chehrehasa, F., Meedeniya, A., Casart, Y., Logue, C.-A., Hirst, R. G., Peak, I. R., Mackay-Sim, A. & Beacham, I. R. (2009). Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 199, 1761-1770.
41. Park, H.-S., Francis, K. P., Yu, J. & Cleary, P. P. (2003). Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171, 2532-2537. (Pubitemid 37025563)
42. Passalacqua, K. D. & Bergman, N. H. (2006). Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Future Microbiol 1, 397-415.
43. Redmond, C., Baillie, L. W. J., Hibbs, S., Moir, A. J. G. & Moir, A. (2004). Identification of proteins in the exosporium of Bacillus anthracis. Microbiology 150, 355-363. (Pubitemid 38220038)
44. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493-497.
45. Roy, C. J., Hale, M., Hartings, J. M., Pitt, L. & Duniho, S. (2003). Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in Balb/c mice. Inhal Toxicol 15, 619-638. (Pubitemid 36648207)
46. Sanz, P., Teel, L. D., Alem, F., Carvalho, H. M., Darnell, S. C. & O'Brien, A. D. (2008). Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect Immun 76, 1036-1047. (Pubitemid 351428063)
47. Setlow, P. (2006). Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 101, 514-525.
48. Stokes, M. G. M., Titball, R. W., Neeson, B. N., Galen, J. E., Walker, N. J., Stagg, A. J., Jenner, D. C., Thwaite, J. E., Nataro, J. P. & other authors (2007). Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun 75, 1827-1834.
49. Tam, M. A., Rydström, A., Sundquist, M. & Wick, M. J. (2008). Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more. Immunol Rev 225, 140-162.
50. Thomas, R. J., Webber, D., Sellors, W., Collinge, A., Frost, A., Stagg, A. J., Bailey, S. C., Jayasekera, P. N., Taylor, R. R. & other authors 2008). Characterisation and deposition of respirable large and small particle bioaerosols. Appl Environ Microbiol 74, 6437-6443.
51. Thomas, R. J., Webber, D., Collinge, A., Stagg, A. J., Bailey, S. C., Nunez, A., Gates, A., Jayasekera, P. N., Taylor, R. R. & other authors (2009). Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols. Infect Immun 77, 1315-1323.
52. Todd, S. J., Moir, A. J. G., Johnson, M. J. & Moir, A. (2003). Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium. J Bacteriol 185, 3373-3378. (Pubitemid 36617749)
53. Tutrone, W. D., Scheinfeld, N. S. & Weinberg, J. M. (2002). Cutaneous anthrax: a concise review. Cutis 69, 27-33.
54. Twenhafel, N. A., Leffel, E. & Pitt, M. L. M. (2007). Pathology of inhalational anthrax infection in the African Green monkey. Vet Pathol 44, 716-721. (Pubitemid 47451244)
55. Van den Broeck, W., Derore, A. & Simeons, P. (2006). Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312, 12-19. (Pubitemid 43795993)
56. Vasconcelos, D., Barnewall, R., Babin, M., Hunt, R., Estep, J., Nielsen, C., Carnes, R. & Carney, J. (2003). Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab Invest 83, 1201-1209. (Pubitemid 37013055)
57. Welkos, S. L., Keener, T. J. & Gibbs, P. H. (1986). Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51, 795-800. (Pubitemid 16162978)
58. Williamson, E. D., Hodgson, I., Walker, N. J., Topping, A. W., Duchars, M. G., Mott, J. M., Estep, J., LeButt, C., Flick-Smith, H. C. & other authors (2005). Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Infect Immun 73, 5978-5987. (Pubitemid 41193036)
59. Zaucha, G. M., Pitt, L. M., Estep, J., Ivins, B. E. & Friedlander, A. M. (1998). The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med 122, 982-992. (Pubitemid 28521045)